L Cöster

3.7k total citations
47 papers, 3.0k citations indexed

About

L Cöster is a scholar working on Cell Biology, Molecular Biology and Rheumatology. According to data from OpenAlex, L Cöster has authored 47 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Cell Biology, 25 papers in Molecular Biology and 8 papers in Rheumatology. Recurrent topics in L Cöster's work include Proteoglycans and glycosaminoglycans research (30 papers), Glycosylation and Glycoproteins Research (19 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). L Cöster is often cited by papers focused on Proteoglycans and glycosaminoglycans research (30 papers), Glycosylation and Glycoproteins Research (19 papers) and Rheumatoid Arthritis Research and Therapies (8 papers). L Cöster collaborates with scholars based in Sweden, United States and United Kingdom. L Cöster's co-authors include Anders Malmström, L Å Fransson, I Carlstedt, Solbritt Rantapää‐Dahlqvist, Nils Feltelius, Lars Klareskog, L. Jacobsson, Johan Askling, Eva Baecklund and Tore Saxne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

L Cöster

46 papers receiving 2.9k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
L Cöster 1.3k 1.1k 929 454 359 47 3.0k
C. William Castor 576 0.5× 573 0.5× 573 0.6× 330 0.7× 380 1.1× 80 2.3k
Anna Engström‐Laurent 1.6k 1.3× 645 0.6× 971 1.0× 183 0.4× 199 0.6× 63 3.2k
Christopher J. Handley 1.3k 1.0× 1.8k 1.6× 864 0.9× 106 0.2× 225 0.6× 126 4.2k
Thomas Hunziker 468 0.4× 1.3k 1.2× 427 0.5× 315 0.7× 585 1.6× 105 4.1k
Biagio Didona 662 0.5× 502 0.4× 478 0.5× 144 0.3× 328 0.9× 88 2.1k
Michael D. Tharp 282 0.2× 701 0.6× 631 0.7× 178 0.4× 1.2k 3.4× 76 2.8k
John Harper 1.1k 0.9× 379 0.3× 1.0k 1.1× 94 0.2× 652 1.8× 120 5.8k
Norbert Sepp 227 0.2× 824 0.7× 794 0.9× 296 0.7× 1.2k 3.3× 115 3.5k
Lawrence S. Chan 539 0.4× 1.5k 1.3× 531 0.6× 350 0.8× 912 2.5× 121 4.6k
Kaisa Tasanen 1.0k 0.8× 856 0.8× 913 1.0× 81 0.2× 274 0.8× 129 3.6k

Countries citing papers authored by L Cöster

Since Specialization
Citations

This map shows the geographic impact of L Cöster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Cöster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Cöster more than expected).

Fields of papers citing papers by L Cöster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Cöster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Cöster. The network helps show where L Cöster may publish in the future.

Co-authorship network of co-authors of L Cöster

This figure shows the co-authorship network connecting the top 25 collaborators of L Cöster. A scholar is included among the top collaborators of L Cöster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Cöster. L Cöster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chatzidionysiou, Katerina, Carl Turesson, Annika Teleman, et al.. (2012). A Multicenter, Randomized, Controlled, Open-Label Pilot Study of the Feasibility of Discontinuation of Adalimumab in Rheumatoid Arthritis Patients in Stable Clinical Remission. Arthritis & Rheumatism. 64. 12 indexed citations
2.
Kastbom, Alf, L Cöster, Lisbeth Ärlestig, et al.. (2012). Influence ofFCGR3Agenotype on the therapeutic response to rituximab in rheumatoid arthritis: an observational cohort study. BMJ Open. 2(5). e001524–e001524. 37 indexed citations
3.
Cöster, L, et al.. (2012). Different types of tissue composition in inflammatory or reparative upper airway disorders. Rhinology Journal. 50(4). 393–401. 5 indexed citations
4.
Askling, Johan, Ronald van Vollenhoven, Fredrik Granath, et al.. (2009). Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?. Arthritis & Rheumatism. 60(11). 3180–3189. 189 indexed citations
5.
6.
Askling, Johan, Eva Baecklund, Fredrik Granath, et al.. (2008). Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register. Annals of the Rheumatic Diseases. 68(5). 648–653. 197 indexed citations
7.
Gerdle, Björn, et al.. (2008). Prevalence of widespread pain and associations with work status: a population study. BMC Musculoskeletal Disorders. 9(1). 102–102. 125 indexed citations
8.
Fransson, Lars‐Âke, Ingemar Carlstedt, L Cöster, & Anders Malmström. (2007). The Functions of the Heparan Sulphate Proteoglycans. Novartis Foundation symposium. 124. 125–142. 2 indexed citations
9.
Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for cardiovascular disease. Results from the National Swedish Monitoring-Program for Biologies in Ra (ARTIS).. Arthritis & Rheumatism. 54.
10.
Askling, Johan, Michael Fored, Lena Brandt, et al.. (2006). TNF-antagonist treatment and risk of hospitalisation for infection. Results from the National Swedish Monitoring-Program for Biologics in RA (ARTIS).. Arthritis & Rheumatism. 54. 1 indexed citations
11.
Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of tuberculosis in rheumatoid arthritis and following anti-TNF treatment. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64. 3 indexed citations
12.
Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk of cardiovascular morbidity and mortality following TNF-blockade. Preliminary results of an ongoing Swedish monitoring-programme of biologics in RA. Annals of the Rheumatic Diseases. 64. 448–449. 2 indexed citations
13.
Askling, Johan, C. Michael Fored, Lena Brandt, et al.. (2005). Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis & Rheumatism. 52(7). 1986–1992. 312 indexed citations
14.
Cöster, L, Ingemar Carlstedt, Sally Kendall, et al.. (1986). Structure of proteoheparan sulfates from fibroblasts. Confluent and proliferating fibroblasts produce at least three types of proteoheparan sulfates with functionally different core proteins.. Journal of Biological Chemistry. 261(26). 12079–12088. 42 indexed citations
15.
Fransson, L Å, I Carlstedt, L Cöster, & Anders Malmström. (1983). Proteoheparan sulfate from human skin fibroblasts. Evidence for self-interaction via the heparan sulfate side chains.. Journal of Biological Chemistry. 258(23). 14342–14345. 44 indexed citations
16.
Carlstedt, I, L Cöster, Anders Malmström, & L Å Fransson. (1983). Proteoheparan sulfate from human skin fibroblasts. Isolation and structural characterization.. Journal of Biological Chemistry. 258(19). 11629–11635. 54 indexed citations
17.
Cöster, L, et al.. (1983). The core protein of fibroblast proteoheparan sulphate consists of disulphide-bonded subunits. Biochemical Journal. 215(2). 417–419. 34 indexed citations
18.
Carlstedt, I, L Cöster, & Anders Malmström. (1981). Isolation and characterization of dermatan sulphate and heparan sulphate proteoglycans from fibroblast culture. Biochemical Journal. 197(1). 217–225. 83 indexed citations
19.
Cöster, L, I Carlstedt, & Anders Malmström. (1979). Isolation of 35S- and 3H-labelled proteoglycans from cultures of human embryonic skin fibroblasts. Biochemical Journal. 183(3). 669–681. 67 indexed citations
20.
Sjöberg, Ingrid, I Carlstedt, L Cöster, Anders Malmström, & L Å Fransson. (1979). Structure and metabolism of sulphated glycosaminoglycans in cultures of human fibroblasts. Structural characteristics of co-polymeric galactosaminoglycans in sequential extracts of fibroblasts during pulse-chase experiments. Biochemical Journal. 178(2). 257–270. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. William Castor Breakdown of academic impact, for papers by Anna Engström‐Laurent Breakdown of academic impact, for papers by Christopher J. Handley Breakdown of academic impact, for papers by Thomas Hunziker Breakdown of academic impact, for papers by Biagio Didona Breakdown of academic impact, for papers by Michael D. Tharp Breakdown of academic impact, for papers by John Harper Breakdown of academic impact, for papers by Norbert Sepp Breakdown of academic impact, for papers by Lawrence S. Chan Breakdown of academic impact, for papers by Kaisa Tasanen
Rankless by CCL
2026